Our results have important implications in the process of extravasation of tumor cells at late stages of the metastasis and could be the basis for the development of new therapies using NOS inhibitors or NAC in combination with other drugs as therapeutic strategy to prevent metastasis in breast cancer. This evidence concerns the gene NOS1 and neoplasm.